Atlas Trials

Platinum-refractory Ovarian Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Platinum-refractory Ovarian Cancer

RecordFirmDate
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) (NCT05281471)Genelux Corporation2022-08-31

Track Platinum-refractory Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.